NIH 2021 OT2 HL |
Curing Sickle Cell Disease with CRISPR-Cas9 genome editing Walters, Mark C. / University of California San Francisco |
|
NIH 2020 OT2 HL |
Curing Sickle Cell Disease with CRISPR-Cas9 genome editing Walters, Mark C. / University of California San Francisco |
|
NIH 2019 OT2 HL |
Curing Sickle Cell Disease with CRISPR-Cas9 genome editing Walters, Mark C. / University of California San Francisco |
|